ArticleDermatology and therapy2019

Remission Duration and Long-Term Outcomes in Patients with Moderate-to-Severe Psoriasis Treated by Biologics or Tofacitinib in Controlled Clinical Trials: A 15-Year Single-Center Experience.

Yi-Wei Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.